Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes

Stig Palm; Tom Bäck; Sture Lindegren; Ragnar Hultborn; Lars Jacobsson; Per Albertsson

doi:10.2967/jnumed.117.201285

Research ArticleTheranostics

Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes

Stig Palm, Tom Bäck, Sture Lindegren, Ragnar Hultborn, Lars Jacobsson and Per Albertsson

Journal of Nuclear Medicine April 2018, 59 (4) 646-651; DOI: https://doi.org/10.2967/jnumed.117.201285

Stig Palm

1Department of Radiation Physics, Institute for Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tom Bäck

1Department of Radiation Physics, Institute for Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sture Lindegren

1Department of Radiation Physics, Institute for Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ragnar Hultborn

2Department of Oncology, Institute for Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lars Jacobsson

1Department of Radiation Physics, Institute for Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Per Albertsson

2Department of Oncology, Institute for Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 59, Issue 4

April 1, 2018

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes

Stig Palm, Tom Bäck, Sture Lindegren, Ragnar Hultborn, Lars Jacobsson, Per Albertsson

Journal of Nuclear Medicine Apr 2018, 59 (4) 646-651; DOI: 10.2967/jnumed.117.201285

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes

Stig Palm, Tom Bäck, Sture Lindegren, Ragnar Hultborn, Lars Jacobsson, Per Albertsson

Journal of Nuclear Medicine Apr 2018, 59 (4) 646-651; DOI: 10.2967/jnumed.117.201285

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Intraperitoneal {alpha}-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations
Radiolabeled Antibodies Against Mullerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
Penetrating the Barriers to Successful {alpha}-Radioimmunotherapy

Google Scholar

Theranostics

Terbium-161, a Promising New Theranostic Radionuclide
Association of change in PSMA avid tumor burden during 177Lu-PSMA-617 therapy with overall survival: Should mid-point PET become standard protocol?
Correlation of baseline Ga-68 PSMA PET bone tumor volume with risk of bone marrow related side effects after receiving treatment of Lu-177 PSMA

Show more Theranostics

Basic

Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression

Show more Basic

Keywords

alpha-particle therapy
biokinetic modeling
211At
radioimmunotherapy
ovarian cancer

Main menu

User menu

Search

Model of Intraperitoneal Targeted α-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Basic

Similar Articles

Keywords